This is a general term for any disease affecting the uvea. The uvea is the middle layer of the eye, containing the iris, ciliary body, and choroid.
Every report comes from a Lived member, sent anonymously.
Have you tried Humira (Adalimumab) for Uveal Diseases?
Uveal diseases are conditions that affect the uvea, the middle layer of the eye. The uvea sits between the tough white outer coat and the light-sensing retina at the back. It has three parts: the iris (the colored ring around the pupil), the ciliary body (which helps the lens focus) and the choroid (a layer of blood vessels that nourishes the retina). This is an umbrella term, and the two conditions behind most uveal disease are very different. Uveitis is inflammation inside the eye. It often starts suddenly with eye pain, redness, blurry vision, floaters and sensitivity to light, and it can damage vision if it isn't treated. Uveal melanoma is a rare cancer that grows from the pigment cells of the uvea. It is the most common eye cancer in adults, and it often causes no symptoms at first. What the diagnosis means for you depends on which of these you have and which part of the uvea is involved.
Uveitis happens when the immune system becomes active inside the eye. Sometimes that is a response to an infection, such as shingles, toxoplasmosis, syphilis or cytomegalovirus (CMV). Sometimes the immune system attacks healthy eye tissue, often alongside a body-wide condition such as ankylosing spondylitis (an inflammatory arthritis of the spine), sarcoidosis, psoriasis, Behcet's disease, inflammatory bowel disease or multiple sclerosis. Injury can also trigger it. In many people, no cause is found. Uveitis is most common between ages 20 and 60, and smoking raises the risk. Uveal melanoma is more common with older age and in people with a fair complexion: fair skin that burns easily, and blue, green or other light-colored eyes. Having these traits does not mean someone will develop it, and it also occurs in people without any known risk factor.
Both conditions are found with a careful eye examination. The eye doctor uses drops to widen (dilate) the pupil and looks inside the eye with a microscope and light, checking the front of the eye for inflammatory cells and the back of the eye for inflammation or a growth. Imaging such as optical coherence tomography (a light-based scan of the retina's layers) or dye tests that photograph blood flow in the eye may add detail. For uveitis, finding the inflammation is only half the job. Because it can be the first sign of an infection or a body-wide immune disease, the doctor will ask about your general health and may order blood tests or other tests for infection or immune disease. Some forms prompt specific checks, such as magnetic resonance imaging (MRI) of the brain and spine to look for multiple sclerosis when the inflammation is in the middle of the eye. Identifying an infection matters because infection is treated differently from immune-driven inflammation. Uveal melanoma is usually diagnosed from its appearance on exam and on ultrasound of the eye, so a biopsy is rarely needed. Melanoma is sometimes discovered on a routine dilated eye exam before it causes any symptoms. Once it is found, tests such as liver blood tests and scans check whether it has spread, since the liver is a common site.
Uveitis treatment aims to quiet the inflammation quickly, relieve pain and prevent lasting damage. Steroid medicines are the mainstay. Front-of-the-eye uveitis is usually treated with prescription steroid eye drops, often with drops that dilate the pupil to ease pain. Inflammation further back may need steroid pills, an injection of steroid in or around the eye, or a small implant placed in the eye that releases steroid slowly. If an infection is the cause, it is treated with the matching antibiotic or antiviral medicine. Steroids work well but raise the risk of cataracts (clouding of the lens) and glaucoma (raised eye pressure that can damage the optic nerve), so regular eye pressure checks are part of treatment. When uveitis keeps coming back or needs long-term steroids, doctors may add a medicine that calms the immune system, which lets the steroid dose come down. Adalimumab (Humira) is an injected biologic medicine approved for non-infectious uveitis that affects the middle or back of the eye in adults and children 2 and older; biosimilar versions are also available, and their approved uses can differ. These medicines need monitoring because they can make infections more likely. Uveal melanoma is managed by specialists in eye cancer. Small tumors that aren't growing may be watched with regular photographs and scans. Most others are treated with radiation, often plaque therapy, in which a small disk carrying radioactive seeds is stitched to the outside of the eye over the tumor and removed when the treatment is complete. Radiation is aimed at the tumor while sparing nearby tissue, which often allows the eye to be kept. Laser or heat treatments are used for some small tumors. When vision can't be saved and the tumor is large or causing other damage, the eye may be removed.
Uveitis can be a single episode, a problem that returns, or a long-term condition. With treatment, most attacks of front-of-the-eye uveitis settle within days to weeks, but flares often come back, so it helps to learn your own early signs. Uveitis affecting the back of the eye tends to last longer, from months to years, and can leave some permanent vision change even with good care. Complications such as cataract, glaucoma or fluid within the retina may need their own treatment. Expect frequent visits while a flare is active and regular checkups afterward, sometimes with a rheumatologist or other specialist if a body-wide condition is involved. After treatment for uveal melanoma, follow-up has two aims: checking the treated eye and watching for spread elsewhere in the body, especially the liver. Iris melanomas tend to grow slowly and rarely spread, while those in the ciliary body or choroid are more likely to spread. Monitoring usually continues for years. If an eye is removed, an artificial eye is fitted to match the other eye's size and color.
See an eye doctor the same day if you have eye pain, a red eye with sensitivity to light, blurred or reduced vision, or a sudden increase in floaters. These are the typical signs of uveitis, and prompt treatment protects vision. If you already have uveitis, contact your eye care team as soon as you notice a flare starting. Sudden new flashes of light, a shower of new floaters, or a shadow or curtain over part of your vision can mean the retina is tearing or pulling away, a known complication of uveitis. Get care right away from an eye doctor or an emergency room, even if there is no pain. Book an eye exam soon for changes that have developed slowly or lingered, such as a new dark spot on the iris, a change in the size or shape of the pupil, or flashes or blurring that don't go away. If you take steroids or immune-calming medicine, report signs of infection to your prescriber.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Uveal Diseases is like, what's helped you, or ask the community a question.